Lokal- und Ganzkörperdiagnostik weiblicher Beckentumore

Abstract

Integrated positron emission tomography (PET) and magnetic resonance imaging (MRI) scanning has recently become established in clinical imaging. Various studies have demonstrated the great potential of this new hybrid imaging procedure for applications in the field of oncology and the diagnostics of inflammatory processes. With initial studies demonstrating the feasibility and high diagnostic potential of PET/MRI comparable to PET-computed tomography (CT), the focus of future studies should be on the identification of application fields with a potential diagnostic benefit of PET/MRI over other established diagnostic tools. Both MRI and PET/CT are widely used in the diagnostic algorithms for malignancies of the female pelvis. A simultaneous acquisition of PET and MRI data within a single examination provides complementary information which can be used for a more comprehensive evaluation of the primary tumor as well as for whole body staging. Therefore, the aim of this article is to outline potential clinical applications of integrated PET/MRI for the diagnostic work-up of primary or recurrent gynecological neoplasms of the female pelvis.

PET/MR: aktuelle Einsatzmöglichkeiten in der onkologischen Diagnostik

“…Durch die hohe Sensitivität der 18 F-FDG-PET für Tumorrezidive und die exakte morphologische Korrelation mit der MRT bietet die 18 F-FDG-PET/MR einen deutlichen Mehrwert. Erste Studien zeigen sowohl in der Primär-als auch in der Rezidivdiagnostik vielversprechende Ergebnisse, die jedoch durch prospektive Studien bestätigt werden müssen[23].…”